Activated PI3K-delta syndrome

Search Trials
A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Status:
Recruiting
Last Changed:
Apr 11, 2022
First Changed:
Jun 7, 2021
Disease(s):
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Intervention(s):
TemanogrelPlacebo
Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients
Status:
Completed
Last Changed:
Oct 2, 2019
First Changed:
Jun 16, 2014
Disease(s):
Hodgkin's Lymphoma
Intervention(s):
TGR-1202 + brentuximab vedotin
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
Status:
Recruiting
Last Changed:
May 13, 2022
First Changed:
Nov 21, 2019
Disease(s):
Crohn's Disease
Intervention(s):
EtrasimodEtrasimodPlacebo
Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects With Crohn's Disease Experiencing Abdominal Pain
Status:
Completed
Last Changed:
Sep 11, 2019
First Changed:
May 16, 2017
Disease(s):
Crohn's Disease
Intervention(s):
APD371

Connect. Empower. Inspire.